Glucose as a Mediator of Self-control Performances in Patients With Schizophrenia
NCT ID: NCT01563016
Last Updated: 2012-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2012-04-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to investigate whether the exertion of self-control reduces blood glucose,
* to examine whether low level of blood glucose deteriorates subsequent self-control performances
* to examine whether restoring the glucose level eliminates these impairments, in schizophrenic patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Energetics and Glutamate in Schizophrenia
NCT06236048
Metformin Treatment on Cognitive Impairment of Schizophrenia
NCT05838573
Effectiveness of Exergames on Cognitive, Social Functionamong Chronic Schizophrenia
NCT05933356
Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking Schizophrenia
NCT05301660
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
NCT02964923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glucose & Depleting
participants will perform in a depleting task and receive a glucose drink
glucose drink
participants will receive a drink rich in glucose
Glucose & non-depleting
participants will perform in a non-depleting task and receive a glucose drink
glucose drink
participants will receive a drink rich in glucose
Placebo & depleting
participants will perform in a depleting task and receive a placebo drink
No interventions assigned to this group
Placebo & non depleting
participants will perform in a non depleting task and receive a placebo drink
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
glucose drink
participants will receive a drink rich in glucose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* DSM-IV diagnosis of schizophrenia, schizoaffective disorder, schizophreniform psychosis, brief psychosis, psychosis NOS or delusional disorder
* Cantonese-speaking Chinese
* Ability to understand the nature of the study and sign informed consent
Exclusion Criteria
* Known history of intellectual disability
* Priority Follow Up (Subtarget or Target)
* All allergic to any sugar or artificial sweeteners
* Diabetics
* Physical Disability
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Mary Hospital, Hong Kong
OTHER
The University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric YH Chen, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Hong Kong
Hong Kong, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
selfcontrolvsglucose
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.